Most Read Articles
3 days ago
Cardiac biomarkers are useful for identifying community-acquired pneumonia (CAP) patients with an elevated risk of early and long-term cardiovascular (CV) events, according to a study.
Yesterday
Tofogliflozin is safe and effective for elderly patients with type 2 diabetes mellitus (T2DM), regardless of insulin and oral antidiabetic drugs, reports a new Japan study.
6 days ago
Pulmonary function has potential predictive value for future increases in arterial stiffness and its progression, as reported in a recent study.
5 days ago
Systolic blood pressure appears to have a strong association with aneurysmal subarachnoid haemorrhage (aSAH) but not with unruptured intracranial aneurysm (UIA), whereas current smoking and female sex are risk factors for both conditions, a study has found.

Integrate genetic testing into local routine oncology care

Dr Joslyn Ngu
04 Dec 2017

Identification of BRCA mutation in ovarian cancer is vital because it allows better risk management and there is evidence that carriers may benefit from new treatment modalities, said Professor Woo Yin Ling, consultant gynaecological oncologist at the University of Malaya.

Locally, 12 percent of ovarian cancer patients are carriers of a germline BRCA1 or BRCA2 mutations. Genetic counselling plays a crucial role in cancer genetics; interpretation of the results of genetic testing is unique to every individual and her situation, she explained. Unfortunately, there are several barriers to overcome, such as lack of population-based data on genetic mutation in Asians, lack of access to BRCA testing, lack of awareness among healthcare professionals, complex interpretation of genetic test results and psychosocial barriers.

Together with Cancer Research Malaysia, Woo and other healthcare professionals are conducting the MaGiC (MAinstreaming GenetIc Counselling for genetic testing of BRCA1 and BRCA2 in ovarian cancer patients in Malaysia) trial as part of an effort to make genetic counselling mainstream in the country. The study aims to establish a local population-based cohort of ovarian cancer patients to determine the prevalence of mutations, feasibility of mainstreaming BRCA1 and BRCA2 testing for ovarian cancer and psychosocial impact of genetic testing.

Preliminary findings showed the identification of 20 new BRCA carriers from different states in Malaysia. Previously, identified BRCA carriers were mostly from Klang Valley. With the identification of carriers outside of Klang Valley, risk management protocols were then set up in those hospitals and training is provided for clinicians to form multidisciplinary teams for risk management, said Woo. Another preliminary finding is that majority of patients felt counselling done by their doctors were valuable; indicating the importance of physician-led genetic counselling.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
3 days ago
Cardiac biomarkers are useful for identifying community-acquired pneumonia (CAP) patients with an elevated risk of early and long-term cardiovascular (CV) events, according to a study.
Yesterday
Tofogliflozin is safe and effective for elderly patients with type 2 diabetes mellitus (T2DM), regardless of insulin and oral antidiabetic drugs, reports a new Japan study.
6 days ago
Pulmonary function has potential predictive value for future increases in arterial stiffness and its progression, as reported in a recent study.
5 days ago
Systolic blood pressure appears to have a strong association with aneurysmal subarachnoid haemorrhage (aSAH) but not with unruptured intracranial aneurysm (UIA), whereas current smoking and female sex are risk factors for both conditions, a study has found.